Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

CLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

Journal of Veterinary Cardiology is a leading scientific publication dedicated to the field of veterinary cardiology, published by ELSEVIER. With an ISSN of 1760-2734 and E-ISSN 1875-0834, this journal plays a crucial role in disseminating cutting-edge research and clinical insights into animal cardiovascular health. With a strong emphasis on the interrelations of veterinary science and physiology, it boasts an impressive ranking in the Q1 category for miscellaneous veterinary studies and a significant position at 69th percentile in general veterinary rankings according to Scopus. Researchers, professionals, and students are encouraged to engage with the journal's diverse array of articles that span basic research to clinical applications, bridging knowledge gaps in veterinary cardiology. This important resource showcases impactful studies from its inception in 1999 and remains a steadfast conduit for the advancement of knowledge in the field through 2024 and beyond.

Journal of Cardiovascular Echography, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, serves as a premier platform for global researchers, medical professionals, and students dedicated to the ever-evolving fields of cardiology and cardiovascular imaging. With the ISSN 2211-4122 and E-ISSN 2347-193X, this journal provides access to cutting-edge research from 2011 to 2024, offering insights into the latest advancements in echocardiographic techniques and their clinical applications. Despite its current classification in the Q3 quartile within both Cardiology and Cardiovascular Medicine as well as Radiology, Nuclear Medicine, and Imaging, it continues to make meaningful contributions to the academic community, ranking 234th in the Scopus category for Radiology and 278th in Cardiology. The Journal of Cardiovascular Echography is committed to furthering knowledge and fostering collaboration among researchers by sharing critical developments in the field, making it an essential resource for anyone looking to stay abreast of transformational changes in cardiovascular diagnostics.

Radiology-Cardiothoracic Imaging, published by the Radiological Society of North America (RSNA), is a leading peer-reviewed journal dedicated to advancing knowledge in the field of cardiothoracic radiology. With an ISSN of 2638-6135 and a remarkable 2023 Scopus ranking of #5 out of 333 in its category, the journal stands out in the Q1 tier for Radiology, Nuclear Medicine, and Imaging, showcasing its significant impact and high-quality research contributions. The journal is committed to providing an open platform for innovative research, insightful reviews, and clinical studies that address the complexities of cardiothoracic imaging, thereby facilitating the enhancement of diagnostic and therapeutic strategies. Operating out of Oak Brook, Illinois, the journal aims to engage a diverse audience of researchers, professionals, and students, fostering collaboration and knowledge exchange within this vital area of radiological science. With a convergence of years extending from 2019 to 2024, Radiology-Cardiothoracic Imaging remains at the forefront of emerging trends and findings, making it an essential resource for anyone passionate about the evolving landscape of cardiothoracic imaging.

Cardiovascular Therapeutics is a renowned Open Access journal, published by WILEY-HINDAWI, that has been at the forefront of advancing knowledge in the field of cardiology and cardiovascular medicine since its establishment. With a strong commitment to disseminating high-quality research, the journal has successfully positioned itself within the Q2 quartile in multiple categories, including Cardiology and Cardiovascular Medicine, Medicine (miscellaneous), and Pharmacology. The journal is indexed in Scopus, achieving impressive rankings, such as #95 out of 387 in Cardiology, and #87 out of 272 in Medical Pharmacology. Situated in the United Kingdom, Cardiovascular Therapeutics embraces an Open Access model since 2019, ensuring that groundbreaking research is accessible to researchers, practitioners, and students across the globe. The journal is dedicated to publishing original research articles, reviews, and clinical studies that contribute to the understanding and treatment of cardiovascular diseases, making it an essential resource for those invested in improving patient outcomes and advancing therapeutic strategies in this vital area of medicine.

Open Cardiovascular Medicine Journal is a notable scholarly platform published by Bentham Science Publishers Ltd, dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. With an E-ISSN of 1874-1924, this open-access journal has been a beacon for researchers and clinicians alike since its inception in 2009. Acting as a conduit for the latest research findings, the journal fosters interdisciplinary collaboration and innovation, contributing to the overall progress in cardiovascular health. Although currently ranked in the 26th percentile among cardiology journals, it emphasizes high-quality, peer-reviewed articles that uphold the rigorous standards of academic integrity. The journal also benefits from a robust editorial team and an array of publication options, ensuring accessibility and visibility of crucial cardiovascular research. As it continues its journey through 2023 and beyond, Open Cardiovascular Medicine Journal remains essential for anyone invested in the challenges and advancements within the cardiovascular domain.

Acta Cardiologica Sinica is a distinguished journal dedicated to the advancement of cardiology and cardiovascular medicine, published by the Taiwan Society of Cardiology. Since its inception in 1988, this journal has provided a platform for researchers and clinicians to share cutting-edge findings and insights into cardiac health, cardiovascular diseases, and innovative treatment strategies. With an impressive Q3 classification in the Cardiology category for 2023, the journal is recognized for its contributions to the field, ranked #208 out of 387 in Scopus, placing it within the 46th percentile of medical journals. Although it currently does not offer open access options, it remains a valued resource for the global cardiovascular community. The journal's commitment to disseminating high-quality research papers, reviews, and case studies ensures that it plays a vital role in improving cardiovascular health practices and outcomes. For researchers, professionals, and students alike, Acta Cardiologica Sinica is essential reading for staying informed about the latest developments in cardiology.

METABOLISM-CLINICAL AND EXPERIMENTAL is a premier academic journal published by W B SAUNDERS CO-ELSEVIER INC, with a distinguished history dating back to 1952. This journal serves as a vital repository of knowledge in the fields of Endocrinology, Diabetes, and Metabolism, consistently ranking in the top quartile (Q1) within these categories according to the latest metrics. With an impressive impact factor and recognized for its contributions to Biochemistry, Genetics, and Molecular Biology, it ranks #5 out of 128 in the Scopus database for Endocrinology and #11 out of 244 for Medicine related to Endocrinology, Diabetes, and Metabolism, placing it in the 95th and 96th percentiles, respectively. While the journal does not currently offer open access, it maintains rigorous peer review standards and publishes cutting-edge research that drives forward the understanding of metabolic diseases and clinical practices. By engaging with METABOLISM-CLINICAL AND EXPERIMENTAL, researchers, healthcare professionals, and students can explore groundbreaking advancements and pivotal findings that shape the future of metabolic health.